SF3B1 and myelodysplastic syndrome: In this study, we thus evaluated the effects of SF3B1 knockdown on cell growth, gene expression and splicing in a range of myeloid cell lines and performed RNA sequencing (RNA-Seq) on the CD34+ cells of MDS patients harboring SF3B1 mutations.